Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH1 | P35367 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.38 |
| ▸ | MEN1 | O00255 | 3/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | FAAH | O00519 | 1/20 | 0.35 |
| ▸ | MGLL | Q99685 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | RECQL | P46063 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2940772 | 0.74 | FABP7 (0.36) | ALDH1A1NPSR1FAAHMGLLCYP3A4 | |
| SCHEMBL133189 | 0.74 | ALDH1A1 (0.41) | HRH1ALDH1A1MEN1KMT2ANPSR1 | |
| SCHEMBL1159030 | 0.74 | ALDH1A1 (0.41) | HRH1ALDH1A1MEN1KMT2ANPSR1 | |
| SCHEMBL29353025 | 0.74 | ALDH1A1 (0.41) | HRH1ALDH1A1MEN1KMT2ANPSR1 | |
| SCHEMBL5840557 | 0.72 | ALDH1A1 (0.40) | HRH1ALDH1A1MEN1KMT2ANPSR1 | |
| SCHEMBL33526641 | 0.72 | ALDH1A1 (0.40) | HRH1ALDH1A1MEN1KMT2ANPSR1 | |
| SCHEMBL1931350 | 0.72 | ALDH1A1 (0.40) | HRH1ALDH1A1MEN1KMT2ANPSR1 | |
| Hydrochloric Acid SCHEMBL29639278 | 0.72 | ALDH1A1 (0.40) | HRH1ALDH1A1MEN1KMT2ANPSR1 | |
| SCHEMBL16694717 | 0.72 | GAA (0.39) | HRH1ALDH1A1MEN1KMT2ANPSR1 | |
| SCHEMBL4450995 | 0.70 | LMNA (0.33) | LMNAKDM4ETSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1437356-B1 | Copper complexes and the use thereof | LANXESS DEUTSCHLAND GMBH (DE) | 2006-03-29 | — | — | EP | claimed |
| US-20040198997-A1 | Copper complexes and their use | LANXESS DEUTSCHLAND GMBH (DE) | 2004-10-07 | — | — | US | claimed |
| US-7179946-B2 | Copper complexes and their use | LANXESS DEUTSCHLAND GMBH (DE) | 2007-02-20 | — | — | US | disclosed |
| US-6946577-B2 | Process for the production of aminodiphenylamines | BAYER AKTIENGESELLSCHAFT (DE) | 2005-09-20 | — | — | US | disclosed |
| US-20040198997-A1 | Copper complexes and their use | LANXESS DEUTSCHLAND GMBH (DE) | 2004-10-07 | — | — | US | disclosed |
| US-20040143139-A1 | Process for the production of aminodiphenylamines | LANXESS DEUTSCHLAND GMBH (DE) | 2004-07-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040143139-A1 | Process for the production of aminodiphenylamines | NUDT1, ITPA, NAAA | HRH1 689/4885ALDH1A1 693/4885MEN1 3217/4885 |
| US-20040198997-A1 | Copper complexes and their use | SOD1, SOD3, ITPA | HRH1 4481/4885ALDH1A1 2514/4885MEN1 1256/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.